These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31962283)

  • 1. Known fentanyl use among clients of harm reduction sites in British Columbia, Canada.
    Karamouzian M; Papamihali K; Graham B; Crabtree A; Mill C; Kuo M; Young S; Buxton JA
    Int J Drug Policy; 2020 Mar; 77():102665. PubMed ID: 31962283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada.
    Amlani A; McKee G; Khamis N; Raghukumar G; Tsang E; Buxton JA
    Harm Reduct J; 2015 Nov; 12():54. PubMed ID: 26577516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
    Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
    Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
    Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
    Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services.
    Papamihali K; Collins D; Karamouzian M; Purssell R; Graham B; Buxton J
    PLoS One; 2021; 16(5):e0252090. PubMed ID: 34038452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.
    Kuo M; Shamsian A; Tzemis D; Buxton JA
    Harm Reduct J; 2014 Apr; 11():13. PubMed ID: 24766846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

  • 13. The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City.
    Martinez S; Jones JD; Brandt L; Campbell ANC; Abbott R; Comer SD
    Am J Addict; 2021 Jan; 30(1):65-71. PubMed ID: 32776640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
    Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
    Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
    Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
    Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K
    Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
    Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T
    Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.